Pharmacological inhibition of histone deacetylases for the treatment of cancer, neurodegenerative disorders and inflammatory diseases

Author： Bonfils Claire   Walkinshaw Donald R   Besterman Jeffrey M   Yang Xiang-Jiao   Li Zuomei  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.9, 2008-09, pp. : 1041-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 257-271

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment

By  

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 196-208

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 1, 2009-03 ,pp. : 84-107

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases as Targets for Multiple Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-06 ,pp. : 1005-1026

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3509-3519

Bentham Science Publishers

Access to resources Recommend Favorite